Cough And Cold Tablet, Film Coated
NDC Package 0904-6634-44
Package Information
Cough And Cold (chlorpheniramine maleate, dextromethorphan hbr) tablets is do not exceed recommended doseadults and children 12 years and over: 1 tablet every 6 hours. This formulation utilizes a tablet, film coated delivery system. Marketed by Major Pharmaceuticals, this product is identified by NDC 0904-6634 and is authorized under FDA application M012.
Identification & Billing
- RxCUI: 1421985 - chlorpheniramine maleate 4 MG / dextromethorphan HBr 30 MG Oral Tablet
- RxCUI: 1421985 - chlorpheniramine maleate 4 MG / dextromethorphan hydrobromide 30 MG Oral Tablet
Clinical Specifications
- Histamine H1 Receptor Antagonists - [MoA] (Mechanism of Action)
- Histamine-1 Receptor Antagonist - [EPC] (Established Pharmacologic Class)
- Sigma-1 Agonist - [EPC] (Established Pharmacologic Class)
- Sigma-1 Receptor Agonists - [MoA] (Mechanism of Action)
- Uncompetitive N-methyl-D-aspartate Receptor Antagonist - [EPC] (Established Pharmacologic Class)
- Uncompetitive NMDA Receptor Antagonists - [MoA] (Mechanism of Action)
Regulatory & Marketing
Hierarchy Structure
- 0904 - Major Pharmaceuticals
- 0904-6634 - Cough And Cold
- 0904-6634-44 - 2 BLISTER PACK in 1 CARTON / 8 TABLET, FILM COATED in 1 BLISTER PACK
- 0904-6634 - Cough And Cold
The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.
* Please review the full disclaimer at the bottom of this page.
Frequently Asked Questions
What is the distribution configuration for this product package?
The code 0904-6634-44 identifies a specific commercial package of 2 blister pack in 1 carton / 8 tablet, film coated in 1 blister pack of Cough And Cold, a human over the counter drug labeled by Major Pharmaceuticals. This tablet, film coated is formulated for oral use and contains chlorpheniramine maleate; dextromethorphan hydrobromide as the active substance.
Is this product currently listed with the FDA?
Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Major Pharmaceuticals on March 31, 2017. The current certification is valid through December 31, 2026.
How is this Major Pharmaceuticals product billed for insurance claims?
For medical billing and reimbursement, this package follows the 11-digit CMS format: 00904663444. Quantities are measured in per "each", products billed on a per each basis are usually products dispensed in discreet units.. There are 2 total billable units per package. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.
11-Digit Code Conversion
Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:
Note: The zero is added to the Labeler segment to maintain the 5-4-2 structure.